New Delhi: The Drugs Controller General of India (DCGI) cleared Covaxin trials on children from two to 18 years on Thursday. This is the first time in India that a COVID-19 vaccine will be tested on children.
Covaxin maker Bharat Biotech said its phase 2 and 3 trials would be carried out on 525 healthy volunteers.
According to a government statement, the drug regulator accepted the recommendation of an expert committee on vaccines after careful thought.
The trial involves two vaccine doses injected at day 0 and day 28.
The trials are to take place at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Earlier on Tuesday, the Subject Expert Committee (SEC) on COVID-19 had discussed Bharat Biotech’s application seeking permission to conduct phase 2 and 3 trials “to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years”, NDTV reported.
Bhubaneswar: The opening date of Bhubaneswar and Cuttack Bali Jatras this year face a clash…
Bhubaneswar: A recent study has warned that humans and animals will be wiped out from…
Mumbai: Ever since ‘Pushpa 2: The Rule’ went on floors, speculation was rife that ‘Stree…
Kolkata: Sanjay Roy, the prime suspect in the brutal rape and murder of a Kolkata…
Bhubaneswar: Vigilance officials seized suspected ill-gotten money amounting to Rs 2.8 lakh from an official…
Baripada: A man was saved from drowning in a deep well due to timely rescue…
Mumbai: Actor Arjun Kapoor, who joined the third instalment of Rohit Shetty’s cop universe franchise…
New Delhi: Prime Minister Narendra Modi on Monday strongly condemned the “deliberate attack on a…